Drug Shortage Report for EXELON PATCH 10
| Report ID | 210801 |
| Drug Identification Number | 02302853 |
| Brand name | EXELON PATCH 10 |
| Common or Proper name | Rivastigmine Transdermal Patch |
| Company Name | KNIGHT THERAPEUTICS INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | RIVASTIGMINE |
| Strength(s) | 9.5MG |
| Dosage form(s) | PATCH |
| Route of administration | TRANSDERMAL TRANSDERMAL |
| Packaging size | 9.5 mg/24hr |
| ATC code | N06DA |
| ATC description | ANTI-DEMENTIA DRUGS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2023-11-17 |
| Estimated end date | 2023-12-31 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2023-11-18 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3400 DE MAISONNEUVE BLVD W MONTREAL, QUEBEC CANADA H3Z 3B8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2023-11-18 | French | Compare |
| v1 | 2023-11-18 | English | Compare |
Showing 1 to 2 of 2